Southeast Shoutouts | Finalists announced for “InnoVision Awards”
Transomic Technologies, a privately held company based in Huntsville, has licensed a technology that earned its inventor a Nobel Prize.
From South Carolina:
The finalists for the annual “InnoVision Awards” have been announced. This year’s finalists – three in each of six categories – include both large and small organizations that represent an array of industries “from the upstate to the coast – a true reflection of South Carolina’s robust innovation economy.”
Established in 1999, the annual awards program is overseen by a grass-roots, volunteer-led non-profit organization made up of businesses, organizations, universities, and individuals dedicated to finding innovation and technology in products, services, and education from across the state, and recognizing and honoring peers for achievements in their respective fields.
All finalists will be recognized during the “InnoVision 2023 Meet the Finalists Forum Series” that will be held virtually. Each session will feature finalists in two award categories. Details on dates and more will follow. The winners will be announced at the InnoVision annual awards program November 9 in Columbia.
From Huntsville, AL:
ERS Genomics Limited (ERS) has announced a new license agreement with Transomic Technologies, a privately held company based in Huntsville. The non-exclusive licensing agreement grants Transomic access to ERS’ foundational CRISPR/Cas9 patent portfolio for which ERS Founder Emmanuelle Charpentier received the 2020 Nobel Prize.
According to a news release announcing the licensing agreement, the ERS patent portfolio stands as the definitive collection of proprietary rights to this gene editing technology.
Founded in 2012 and located in the HudsonAlpha Institute for Biotechnology, Transomic’s mission is to equip life science researchers with cutting-edge gene modulation tools derived from the forefront of biotechnology advancements. Specializing in molecular cloning, its portfolio of products and services revolves around vector-based solutions.
ERS Genomics is a biotechnology company based in Dublin, Ireland.
From Research Triangle Park, NC:
Summer is almost over as K-12 students go back to school and universities are getting ready to open. That said, we took note of ODSI, a program of the nonprofit OpenDoors organization that was formed in 2022 by a collective of biotech executives, companies and students to promote workforce diversity in the Triangle’s life sciences companies. WRAL TechWire spotlighted the group’s efforts and one participant in this recent article.